• {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Products

      VYALEV

      Advanced Parkinson’s disease

      PrVYALEV™ is indicated for the treatment of motor fluctuations in patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper- /dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products.

      VYALEV should only be prescribed by neurologists who are experienced in the treatment of patients with Parkinson’s disease.
       

      Please consult the Product Monograph at: https://www.abbvie.ca/content/dam/abbvie-dotcom/ca/en/documents/products/VYALEV_PM_EN.pdf for contraindications, serious warnings and precautions, other warnings and precautions, adverse reactions, interactions, dosing, conditions of clinical use and storage and handling. The Product Monograph is also available by calling: 1-888-704-8271.
       

      This website is intended for Canadian Healthcare Professionals

      Copyright® 2022 AbbVie Corporation. Canada. 

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.